Green and black tea are equally potent stimuli of NO production and vasodilation: New insights into tea ingredients involved

Basic Research in Cardiology

Volumn 104, Issue 1, 2009, Pages 100-110

  Lorenz, Mario ^a   Urban, Janka ^a   Engelhardt, Ulrich ^b   Baumann, Gert ^a   Stangl, Karl ^a   Stangl, Verena ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Catechin; EGCG; ENOS; Theaflavins; Thearubigin; Vasodilation

Indexed keywords

BLACK TEA EXTRACT; CATALASE; CATECHOL DERIVATIVE; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; MACROGOL; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; THEAFLAVIN; THEAFLAVIN 3 MONOGALLATE; THEAFLAVIN 3' MONOGALLATE; THEAFLAVIN 3,3' DIGALLATE; THEARUBIGIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FERMENTATION; FOOD PROCESSING; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; TEA; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; AORTA; BEVERAGES; BRAIN; CATECHIN; CATTLE; ENDOTHELIUM, VASCULAR; HUMANS; HYDROCORTISONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; TEA; TISSUE EXTRACTS; VASODILATION;

EID: 57949095994     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-008-0759-3     Document Type: Article

References (44)

1. Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, Keaney JF Jr (2004) Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 279:46637-46643
2. Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37:693-704
3. Beecher GR (2003) Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr 133:3248S-3254S
4. Collins QF, Liu HY, Pi J, Liu Z, Quon MJ, Cao W (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′ -AMP-activated protein kinase. J Biol Chem 282:30143-30149
5. Determination of substances characteristic of green and black tea. (2005) Part 2: Content of catechins in green tea. Method using high-performance liquid chromatography. International Standard ISO 14502-2:2005
6. Dreger H, Lorenz M, Kehrer A, Baumann G, Stangl K, Stangl V (2008) Characteristics of catechin- and theaflavin-mediated cardioprotection. Exp Biol Med 233:427-433
7. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA (2001) Short- and long term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104:151-156
8. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC (1999) Tea flavonoids may protect against atherosclerosis: The Rotterdam Study. Arch Intern Med 159:2170-2174
9. Graham HN (1992) Green tea composition, consumption, and polyphenol chemistry. Prev Med 21:334-350
10. Haslam E (2003) Thoughts on thearubigins. Phytochemistry 64:61-73
11. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342:1007-1011
12. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D (1997) Antioxidant flavonols and ischemic heart disease in a Welsh population of men: The Caerphilly Study. Am J Clin Nutr 65:1489-1494
13. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ (2002) Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 102:195-201
14. Huang Y, Zhang A, Lau CW, Chen ZY (1998) Vasorelaxant effects of purified green tea epicatechin derivatives in rat mesenteric artery. Life Sci 63:275-283
15. Jochmann N, Lorenz M, Krosigk AV, Martus P, Böhm V, Baumann G, Stangl K, Stangl V (2008) The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 99:863-868
16. Kim JA, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnani M, Quon MJ (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signalling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282:13736-13745
17. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki Study. JAMA 296:1255-1265
18. Lakenbrink C, Lapczynski S, Maiwald B, Engelhardt UH (2000) Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. J Agric Food Chem 48:2848-2852
19. Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY (2001) Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 131:2248-2251
20. Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK (1999) Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate. Carcinogenesis 20:733-736
21. Lorenz M, Jochmann N, von Krosigk A, Martus P, Baumann G, Stangl K, Stangl V (2007) Addition of milk prevents vascular protective effects of tea. Eur Heart J 28:219-223
22. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, Stangl K, Stangl V (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279:6190-6195
23. Manach C, Mazur A, Scalbert A (2005) Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16:77-84
24. McNeill JR, Jurgens TM (2006) A systematic review of mechanisms by which natural products of plant origin evoke vasodilatation. Can J Physiol Pharmacol 84:803-821
25. Menet MC, Sang S, Yang CS, Ho CT, Rosen RT (2004) Analysis of theaflavins and thearubigins from black tea extract by MALDI-TOF mass spectrometry. J Agric Food Chem 52:2455-2461
26. Miller NJ, Castelluccio C, Tijburg L, Rice-Evans C (1996) The antioxidant properties of theaflavins and their gallate esters-radical scavengers or metal chelators? FEBS Lett 392:40-44
27. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA (2002) Tea consumption and mortality after acute myocardial infarction. Circulation 105:2476-2481
28. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49-54
29. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ (2006) Nitric oxide and atherosclerosis: An update. Nitric Oxide 15:265-279.
30. Peters U, Poole C, Arab L (2001) Does tea affect cardiovascular disease? A meta analysis. Am J Epidemiol 154:495-503
31. Riemersma RA, Rice-Evans CA, Tyrrell RM, Clifford MN, Lean ME (2001) Tea flavonoids and cardiovascular health. Q J Med 94:277-282
32. Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T, Mizuno K (2004) Effects of green tea intake on the development of coronary artery disease. Circ J 68:665-670
33. Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Doi Y, Kawano T, Nakagaki O, Takada K, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A (2000) Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10:401-408
34. Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, Kato K, Ikeda M (1989) Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J Exp Med 157:337-343.
35. Stangl V, Dreger H, Stangl K, Lorenz M (2007) Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 73:348-358
36. Stensvold I, Tverdal A, Solvoll K, Foss OP (1992) Tea consumption: relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21:546-553
37. Subramanian N, Venkatesh P, Ganguli S, Sinkar VP (1999) Role of polyphenol oxidase and peroxidase in the generation of black tea theaflavins. J Agric Food Chem 47:2571-2588
38. Sumpio BE, Cordova AC, Berke-Schlessel DW, Qin F, Chen QH (2006) Green tea, the "Asian paradox," and cardiovascular disease. J Am Coll Surg 202:813-825
39. Tanner FC, van der Loo B, Shaw S, Greutert H, Bachschmid MM, Berrozpe M, Rozenberg I, Blau N, Siebenmann R, Schmidli J, Meyer P, Lüscher TF (2007) Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery. Basic Res Cardiol 102:308-317
40. Ullmann U, Haller J, Decourt JD, Girault J, Spitzer V, Weber P (2004) Plasma kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers. Int J Vitam Nutr Res 74:269-278
41. Vinson JA, Teufel K, Wu N (2004) Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem 52:3661-3665
42. Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney JF Jr, Vita JA (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26:95-102
43. Woodward M, Tunstall-Pedoe H (1999) Coffee and tea consumption in the Scottish Heart Health Study follow up: Conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 53:481-487
44. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7:351-354